Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 52 citing Bosi: Autoantibody response to islet transplantation in type 1 diabetes. (0.08 sec) 

Successful islet transplantation

- diabetesjournals.org
EA Ryan, JRT Lakey, BW Paty, S Imes, GS … - Diabetes, 2002 - Am Diabetes Assoc
Clinical islet transplantation is gaining acceptance as a potential therapy,
particularly for subjects who have labile diabetes or problems with hypoglycemic
awareness. The risks of the procedure and long-term outcomes are still not ...
Cited by 488 - Related articles - BL Direct - All 9 versions

Autoimmune polyendocrine syndromes

- shouxi.net
GS Eisenbarth, PA Gottlieb - The New England journal of medicine, 2004 - nejm.org
Disease is determined by a subgroup of T cells that recognize one or more
peptides of the target organ. These peptides are bound in the groove of HLA
molecules and are presented to the T-cell receptor (TCR) of T lymphocytes. ...
Cited by 191 - Related articles - BL Direct - All 16 versions

Islet transplantation as a treatment for diabetes--a work in progress

- shouxi.net
RP Robertson - The New England journal of medicine, 2004 - nejm.highwire.org
In 1993 the Diabetes Control and Complications Trial (DCCT) established the
modern standard of care for the medical management of type 1 diabetes mellitus.
1 The DCCT randomly assigned 1441 patients to conventional or intensive ...
Cited by 174 - Related articles - All 9 versions

The role of T-cells in the pathogenesis of type 1 diabetes: from cause to cure


BO Roep - Diabetologia, 2003 - Springer
Type 1 diabetes mellitus results from a T-cell mediat- ed autoimmune destruction
of the pancreatic beta cells in genetically predisposed individuals. The
knowledge of the immunopathogenesis has increased enormously in the last ...
Cited by 137 - Related articles - BL Direct - All 5 versions

Stratification of type 1 diabetes risk on the basis of islet autoantibody characteristics


P Achenbach, K Warncke, J Reiter, HE Naserke … - Diabetes, 2004 - Am Diabetes Assoc
Family history of type 1 diabetes and autoantibodies to the islet antigens
insulin (IAA), glutamate decarboxylase (GADA), and the protein tyrosine
phosphatase-like protein IA-2 (IA-2A) are strong predictors of type 1 ...
Cited by 90 - Related articles - BL Direct - All 6 versions

Pancreas transplantation: indications and consequences

- endojournals.org
JL Larsen - Endocrine reviews, 2004 - Endocrine Soc
Pancreas transplantation continues to evolve as a strategy in the management of
diabetes mellitus. The first combined pancreas-kidney transplant was reported in
1967, but pancreas transplant now represents a number of procedures, each ...
Cited by 58 - Related articles - All 6 versions

Islet isolation for allotransplantation: variables associated with successful islet yield and …


R Nano, B Clissi, R Melzi, G Calori, P Maffi, B … - Diabetologia, 2005 - Springer
Page 1. Diabetologia (2005) 48: 906–912 DOI 10.1007/s00125-005-1725-3 ARTICLE R.
Nano . B. Clissi . R. Melzi . G. Calori . P. Maffi . B. Antonioli . ...
Cited by 43 - Related articles - All 3 versions

Immunological markers in the diagnosis and prediction of autoimmune type 1a diabetes


WE Winter, N Harris, D Schatz - Clinical Diabetes, 2002 - Am Diabetes Assoc
Several autoantibodies are associated with autoimmune type 1 diabetes.
Measurements of islet autoantibodies can assist in the diagnosis of autoimmune
diabetes, and the detection of islet autoantibodies in nondiabetic ...
Cited by 39 - Related articles - BL Direct - All 2 versions

Risks and side effects of islet transplantation


EA Ryan, BW Paty, PA Senior, AMJ Shapiro - Current Diabetes Reports, 2004 - Springer
Introduction Islet transplantation can deliver many benefits: freedom from
hypoglycemia, stable glucose values, insulin indepen- dence, diet
liberalization, improved graft and patient survival after kidney ...
Cited by 36 - Related articles - BL Direct - All 3 versions

C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve β …


JP Palmer, GA Fleming, CJ Greenbaum, KC … - Diabetes, 2004 - Am Diabetes Assoc
The underlying cause of type 1 diabetes, loss of β-cell function, has become
the therapeutic target for a number of interventions in patients with type 1
diabetes. Even though insulin therapies continue to improve, it remains ...
Cited by 27 - Related articles - All 2 versions


Result Page: 

1

2

3

4

5

6

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google